Neonatal herpes should be a reportable disease

Sexually Transmitted Diseases

Volumn 32, Issue 9, 2005, Pages 521-525

  Handsfield, H Hunter ^a,b,j   Waldo, Ann B ^c   Brown, Zane A ^a   Corey, Lawrence ^a,d   Drucker, Joan L ^e   Ebel, Charles W ^f   Leone, Peter A ^g   Stanberry, Lawrence R ^h   Whitley, Richard J ⁱ  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c GLAXOSMITHKLINE   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e Medika LLC   (United States)

^f American Social Health Association   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; GENITAL HERPES; HEALTH CARE POLICY; HEALTH SURVEY; HERPES; HIGH RISK PATIENT; HUMAN; INCIDENCE; NEWBORN INFECTION; PERINATAL INFECTION; REVIEW; SEXUALLY TRANSMITTED DISEASE; SOCIOECONOMICS;

ANTIVIRAL AGENTS; CENTRAL NERVOUS SYSTEM; EYE; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT, NEWBORN; MASS SCREENING; MOUTH; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE;

EID: 24944440755     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000175292.88090.85     Document Type: Review

References (42)

1. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1111.
2. Corey L, Handsfield HH. Genital herpes and public health: Addressing a global problem. JAMA 2000; 283:791-794.
3. Xu F, McQuillan GM, Kottiri BJ, et al. National seroprevalence and trends in herpes simplex virus type 1 and type 2 infection in the United States, 1988-2000. International Society for Sexually Transmitted Disease Research; Ottawa, Canada; July 27-30, 2003;Abstract 0169.
4. Armstrong GL, Schilllinger J, Markowitz L, et al. Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 2001; 153:912-920.
5. Whitley RJ. Herpes simplex virus infections. In: Knipe DM, Howley PM, eds. Fields Virology, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:282-305.
6. Gutierrez KM, Falkovitz Halpern MS, Maldonado Y, Arvin AM. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis 1999; 180:199-202.
7. Brown ZA, Wald A, Morrow AM, Selke S, Zeh J, Corey L. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289:203-209.
8. Roush S, Birkhead G, Koo D, Cobb A, Fleming D. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA 1999; 282:164-170.
9. Carter A. National Advisory Committee on Epidemiology Subcommittee. Establishing goals, techniques and priorities for national communicable disease surveillance. Can J Infect Dis 1991; 2:37-40.
10. Doherty J-A. Establishing priorities for national communicable disease surveillance. Can J Infect Dis 2000; 11:21-25.
11. Mertz G, Rosenthal SL, Stanberry LR. Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? Sex Transm Dis 2003; 30:801-802.
12. Martin JA, Hamilton BE, Ventura SJ, Manecker F, Park MM. Births: Final data for 2000. Natl Vital Stat Rep 2002; 50:1-101.
13. Centers for Disease Control and Prevention. Final 2002 reports of notifiable diseases. MMWR Morb Mortal Wkly Rep 2003; 52:742-750.
14. Lindegren ML, Byers RH, Thomas P, et al. Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 1999; 282: 531-538.
15. Reef SE, Frey TK, Theall K, et al. The changing epidemiology of rubella in the 1990s: On the verge of elimination and new challenges for control and prevention. JAMA 2002; 287:464-472.
16. Sullivan-Bolyai J, Hull FH, Wilson C, Corey L. Neonatal herpes simplex virus infection in King County, Washington: Increasing incidence and epidemiologic correlates. JAMA 1983; 250:3059-3062.
17. Whitley RJ, Corey L, Arvin A, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988; 158:109-116.
18. Kimberlin DW, Lin C, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108:223-229.
19. Enright AM, Prober CG. Neonatal herpes infection: Diagnosis, treatment and prevention. Semin Neonatol 2002; 7:283-291.
20. Centers for Disease Control and Prevention. Diphtheria. Available at: www.cdc.gov/nip/publications/pink/dip.pdf. Accessed October 29, 2003.
21. Centers for Disease Control and Prevention. Toxic shock syndrome. Available at: www.cdc.gov/ncidod/dbmd/diseaseinfo/toxicshock_t.htm. Accessed October 29, 2003.
22. Centers for Disease Control and Prevention. Guidelines for the prevention and control of congenital syphilis. MMWR Morb Mortal Wkly Rep 1988; 37(suppl 1):1-13.
23. Catotti DN, Clarke P, Catoe KE. Herpes revisited: still a cause for concern. Sex Transm Dis 1993; 20:77-80.
24. Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1987; 316: 240-244.
25. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997; 337:509-515.
26. Brown ZA. HSV-2 specific serology should be offered routinely to antenatal patients. Rev Med Virol 2000; 10:141-144.
27. Ashley-Morrow R, Friedrich D. Inaccuracy of certain commercial enzyme immunoassays in diagnosing genital infections with herpes simplex virus types 1 or 2. Am J Clin Pathol 2003; 120:839-844.
28. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:12-17.
29. American College of Obstetricians and Gynecologists. ACOG practice bulletin: Management of herpes in pregnancy. Int J Gynecol Obstet 2000; 68:165-174.
30. Sullender WM, Yasukawa LL, Schwartz M, et al. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis 1988; 157:164-171.
31. Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD Jr. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996; 87:69-73.
32. Brocklehurst P, Kinghorn G, Carney O, et al. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynecol 1998; 105:275-280.
33. Braig S, Luton O, Edlinger C, et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. Eur J Obstet Gynecol Reprod Biol 2001; 96:55-58.
34. Watts DH, Brown ZA, Money D, et al. A double blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003; 188:836-843.
35. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: A systematic review. Am J Obstet Gynecol 2003; 102:1396-1403.
36. Baker D, Brown Z, Hollier LM, et al. Cost-effectiveness of herpes simplex virus type 2 serological testing and antiviral therapy in pregnancy. Am J Obstet Gynecol 2004 i 191:2074-2084.
37. Barnabas RV, Carabin H, Garnett GP. The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: A health economic analysis. Sex Transm Infect 2002; 78:425-429.
38. Wilkinson D, Barton S, Cowan F. HSV-2 specific serology should not be offered routinely to antenatal patients. Rev Med Virol 2000; 10:145-153.
39. Stanberry L, Cunningham AL, Mindel A, et al. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 2000; 30:549-566.
40. Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347:1652-1661.
41. Koutsavlis AT, Kosatsky T, Cox J, et al. Reporting childhood asthma: Why? Why not? What else? J Public Health Policy 2001; 22:311-319.
42. Institute of Medicine. The Hidden Epidemic; Confronting Sexually Transmitted Disease. Washington, DC, National Academy Press, 1997:86-107.